Tradestie Institutional Equity Comparison Engine

MESO vs VCEL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCEL Overall Edge

VCEL Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vericel Corporation (VCEL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus VCEL at 60.5x Forward P/E and 8.3% operating margin (+26.5% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against VCEL sits in SURGE (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCEL
MESO N/M vs VCEL 60.5x Fwd P/E
Growth & Margin Winner VCEL
Op Margin -42.6% vs 8.3% ยท YoY +390.7% vs +26.5%
Momentum & Technical Winner VCEL
1Y -16.4% vs +43.8% ยท 52W Pos 6% vs 92%
Options & Structure Winner VCEL
UNCLASSIFIED (37th %ile IV) vs SURGE (13th %ile IV)
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
34.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0
VCEL NASDAQ
Vericel Corporation
Biological Products, (No Disgnostic Substances)
$57.27
+0.54% 1D
Market Cap $2.9B
1M Return +42.71%
1Y Return +43.75%
Forward P/E 60.5x
Unified AI Score
35.6 / 100 SELL
Tech 50.0 Fund 32.0 Flow 70.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MESO -16.42% VCEL +43.75% Spread: +60.17 pp (VCEL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MESO TTM Op. Margin: -42.6% VCEL TTM Op. Margin: 8.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs VCEL. Trailing 12-month operating profitability (MESO -42.6% vs VCEL 8.3%) and valuation multiples (MESO N/M vs VCEL 60.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MESO (1) vs VCEL (9)
Institutional Metric MESO VCEL Criterion Row Winner
Market Capitalization Scale $1.7B $2.9B Larger Scale VCEL
Trailing P/E Ratio Valuation N/M 90.3x Lower Multiple VCEL
Forward P/E Ratio Valuation N/M 60.5x Lower Multiple VCEL
Revenue Growth (YoY) Growth +390.7% +26.5% Higher Growth MESO
Operating Margin (TTM) Profitability -42.6% 8.3% Higher Margin VCEL
Net Profit Margin Profitability -47.8% 10.3% Higher Margin VCEL
Return on Equity (ROE) Capital Efficiency -9.9% 9.4% Higher ROE VCEL
52-Week Range Position Momentum 6% ($12โ€“$22) 92% ($29โ€“$60) Stronger Trend VCEL
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 78% Vol 0.30ฮฒ ยท 74% Vol Lower Realized Risk VCEL
Unified Institutional Score Composite Signal 34.6 / 100 (SELL) 35.6 / 100 (SELL) Higher Composite VCEL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MESO vs VCEL Buy Guide
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VCEL SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live VCEL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MESO nor VCEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.